Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Guideline
. 2003 Aug;89 Suppl 1(Suppl 1):S35-49.
doi: 10.1038/sj.bjc.6601083.

Summary report of the Standards, Options and Recommendations for the management of patients with non-small-cell lung carcinoma (2000)

A Depierre  1 , J L Lagrange, S Theobald, P Astoul, P Baldeyrou, E Bardet, B Bazelly, J M Bréchot, J L Breton, J Y Douillard, M Grivaux, P Jacoulet, A Khalil, E Lemarié, Y Martinet, G Massard, B Milleron, T Molina, D Moro-Sibilot, M Paesmans, J L Pujol, E Quoix, E Ranfaing, A Rivière, H Sancho-Garnier, P J Souquet, D Spaeth, A Stoebner-Delbarre, L Thiberville, E Touboul, F Vaylet, J M Vergnon, V Westeel; FNCLCC
Affiliations
Guideline

Summary report of the Standards, Options and Recommendations for the management of patients with non-small-cell lung carcinoma (2000)

A Depierre et al. Br J Cancer. 2003 Aug.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Classification by stage
Figure 2
Figure 2
Radio-occult Lung Cancers
Figure 3
Figure 3
Radio-occult stage 0 or TX, T0, Tis tumours
Figure 4
Figure 4
Pretherapeutic work-up for mediastinal node involvement
Figure 5
Figure 5
Pretherapeutic work-up for extra-thoracic involvement
Figure 6
Figure 6
Pre-therapeutic work-up for extra-thoracic involvement
Figure 7
Figure 7
Stage I and II tumours
Figure 8
Figure 8
Stage IIIA tumours
Figure 9
Figure 9
Stage IIIB
Figure 10
Figure 10
Management of pleural effusion with tumour origin
Figure 11
Figure 11
Stage IV tumours
Figure 12
Figure 12
Surveillance after treatment
See this image and copyright information in PMC

References

    1. Depierre A, Lagrange JL, Theobald S, Astoul P, Baldeyrou P, Bardet E, Bazelly B, Bréchot JM, Breton JL, Douillard JY, Grivaux M, Jacoulet P, Khalil A, Lemarié E, Martinet Y, Massard G, Milleron B, Moro-Sibilot D, Paesmans M, Pujol JL, Quoix E, Ranfaing E, Rivière A, Sancho-Garnier H, Souquet PJ, Spaeth D, Stœbner-Delbarre A, Thiberville L, Touboul E, Vaylet F, Vergnon JM, Westeel V (2002) Fédération Nationale des Centres de Lutte Contre le Cancer, ed. Cancers Broncopulmonaire Non à Petites Cellules (Non-Small-Cell Lung Cancers). Paris: John Libbey EUROTEXT; Standards Options & Recommandations Vol 13
    1. Depierre A, Lagrange JL, Theobald S, Astoul P, Baldeyrou P, Bardet E, Bazelly B, Bréchot JM, Breton JL, Douillard JY, Grivaux M, Jacoulet P, Khalil A, Lemarié E, Martinet Y, Massard G, Milleron B, Molina T, Moro-Sibilot D, Paesmans M, Pujol JL, Quoix E, Ranfaing E, Rivière A, Sancho-Garnier H, Souquet PJ, Spaeth D, Stœbner-Delbarre A, Thiberville L, Touboul E, Vaylet F, Vergnon JM, Westeel V (2003). Standards, Options and Recommendations for the management of non-small cell lung carcinoma patients. Bull Cancer 90: 151–166
    1. Fervers B, Hardy J, Blanc-Vincent MP, Theobald S, Bataillard A, Farsi F, Gory G, Debuiche S, Guillo S, Renaud-Salis JL, Pinkerton R, Bey P, Philip T (2001) SOR: project methodology. Br J Cancer 84 (Suppl 2), 8–16 - PMC - PubMed

MeSH terms